Contemporary Reviews in Cardiovascular Medicine Mechanisms of Coronary Artery Spasm
暂无分享,去创建一个
[1] A. Hata,et al. Angiotensin Converting Enzyme as a Genetic Risk Factor for Coronary Artery Spasm , 2013 .
[2] H. Shimokawa,et al. Clinical Characteristics and Long-Term Prognosis of Vasospastic Angina Patients Who Survived Out-of-Hospital Cardiac Arrest: Multicenter Registry Study of the Japanese Coronary Spasm Association , 2011, Circulation. Arrhythmia and electrophysiology.
[3] Jaime Gonzalez,et al. The role of oxidative stress in the pathophysiology of hypertension , 2011, Hypertension Research.
[4] 髙木 祐介. Clinical characteristics and long-term prognosis of vasospastic angina patients who survived out-of-hospital cardiac arrest : multicenter registry study of the Japanese coronary spasm association , 2011 .
[5] K. Kaikita,et al. Background of guidelines for diagnosis and treatment of patients with vasospastic angina (coronary spastic angina) , 2011 .
[6] H. Shimokawa,et al. Prognostic effects of calcium channel blockers in patients with vasospastic angina--a meta-analysis. , 2010, Circulation journal : official journal of the Japanese Circulation Society.
[7] T. Akasaka,et al. Guidelines for diagnosis and treatment of patients with vasospastic angina (coronary spastic angina) (JCS 2008): digest version. , 2010, Circulation journal : official journal of the Japanese Circulation Society.
[8] H. Soejima. Guidelines for Diagnosis and Treatment of Patients With Vasospastic Angina (Coronary Spastic Angina) (JCS 2008) , 2010 .
[9] J. Mercé,et al. Kounis syndrome: report of 5 cases. , 2010, Journal of investigational allergology & clinical immunology.
[10] A. John Camm,et al. The Esc Textbook of Cardiovascular Medicine , 2009 .
[11] D. Jacobs,et al. Oxidative Stress and Insulin Resistance , 2009, Diabetes Care.
[12] G. Niccoli,et al. Coronary artery vasospasm causing ventricular fibrillation - an external loop recording. , 2009, Resuscitation.
[13] A. Maseri,et al. Role of coronary vasoconstriction in ischemic heart disease and search for novel therapeutic targets. , 2009, Circulation journal : official journal of the Japanese Circulation Society.
[14] F. Crea,et al. Chronic Ischaemic Heart Disease , 2009 .
[15] H. Shimokawa,et al. Myocardial ischemia: current concepts and future perspectives. , 2008, Journal of cardiology.
[16] M. Horie,et al. Effects of a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, fluvastatin, on coronary spasm after withdrawal of calcium-channel blockers. , 2008, Journal of the American College of Cardiology.
[17] K. Hirano. Current topics in the regulatory mechanism underlying the Ca2+ sensitization of the contractile apparatus in vascular smooth muscle. , 2007, Journal of pharmacological sciences.
[18] F. Crea,et al. Current clinical features, diagnostic assessment and prognostic determinants of patients with variant angina. , 2007, International journal of cardiology.
[19] E. Romagnoli,et al. Acute myocardial infarction with normal coronary arteries: role of coronary artery spasm and arrhythmic complications. , 2007, International journal of cardiology.
[20] Juan P Casas,et al. Endothelial nitric oxide synthase gene polymorphisms and cardiovascular disease: a HuGE review. , 2006, American journal of epidemiology.
[21] F. Levy,et al. 5-hydroxytryptamine receptors in the human cardiovascular system. , 2006, Pharmacology & therapeutics.
[22] F. Tondato,et al. Safety of intramyocardial injection of autologous bone marrow cells to treat myocardial ischemia in pigs. , 2006, Cardiovascular revascularization medicine : including molecular interventions.
[23] K. Park,et al. Common adrenergic receptor polymorphisms as novel risk factors for vasospastic angina. , 2006, American heart journal.
[24] J. Taguchi,et al. Coronary artery spasm and the polymorphisms of the endothelial nitric oxide synthase gene. , 2006, Circulation journal : official journal of the Japanese Circulation Society.
[25] F. Crea,et al. Coronary artery spasm induced by capecitabine. , 2006, Journal of cardiovascular medicine.
[26] A. E. Menyar. Drug-induced myocardial infarction secondary to coronary artery spasm in teenagers and young adults. , 2006 .
[27] Ayman A El Menyar. Drug-induced myocardial infarction secondary to coronary artery spasm in teenagers and young adults. , 2006, Journal of postgraduate medicine.
[28] H. Kasanuki,et al. [Disease activities and serum C-reactive protein levels in patients with vasospastic angina pectoris]. , 2005, Journal of cardiology.
[29] M. Fujita,et al. Recent insights into the mechanisms, predisposing factors, and racial differences of coronary vasospasm , 2005, Heart and Vessels.
[30] V. Jayam,et al. Coronary vasospasm and myocardial infarction induced by oral sumatriptan. , 2004, Clinical neuropharmacology.
[31] U. Arora,et al. 5-fluorouracil-induced coronary vasospasm. , 2004, Cancer control : journal of the Moffitt Cancer Center.
[32] E. Romagnoli,et al. Increased platelet sodium–hydrogen exchanger activity in patients with variant angina , 2003, Heart.
[33] C. Napoli,et al. Hypercholesterolemia and Hypertension Have Synergistic Deleterious Effects on Coronary Endothelial Function , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[34] E. Benjamin,et al. Obesity and Systemic Oxidative Stress: Clinical Correlates of Oxidative Stress in The Framingham Study , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[35] M. Wheeler,et al. Episodic coronary artery vasospasm and hypertension develop in the absence of Sur2 K(ATP) channels. , 2002, The Journal of clinical investigation.
[36] H. Tomita,et al. Enhanced Activity of Variant Phospholipase C-&dgr;1 Protein (R257H) Detected in Patients With Coronary Artery Spasm , 2002, Circulation.
[37] A. Takeshita,et al. Suppression of Coronary Artery Spasm by the Rho-Kinase Inhibitor Fasudil in Patients With Vasospastic Angina , 2002, Circulation.
[38] K. Kugiyama,et al. Nitric oxide-mediated vasodilatation is decreased in forearm resistance vessels in patients with coronary spastic angina. , 2001, Japanese circulation journal.
[39] A. Takeshita,et al. Inhibition of myosin phosphatase by upregulated rho-kinase plays a key role for coronary artery spasm in a porcine model with interleukin-1beta. , 2000, Circulation.
[40] R. Mongiardo,et al. Major racial differences in coronary constrictor response between japanese and caucasians with recent myocardial infarction. , 2000, Circulation.
[41] H. Takaoka,et al. Systemic endothelial function is preserved in men with both active and inactive variant angina pectoris. , 1999, The American journal of cardiology.
[42] F. Crea,et al. Circadian distribution of ischemic attacks and ischemia-related ventricular arrhythmias in patients with variant angina. , 1999, Cardiologia.
[43] D. Gutterman. Adventitia-dependent influences on vascular function. , 1999, American journal of physiology. Heart and circulatory physiology.
[44] A. Takeshita,et al. Rho-kinase-mediated pathway induces enhanced myosin light chain phosphorylations in a swine model of coronary artery spasm. , 1999, Cardiovascular research.
[45] A. Maseri,et al. Racial heterogeneity in coronary artery vasomotor reactivity: differences between Japanese and Caucasian patients. , 1999, Journal of the American College of Cardiology.
[46] T. Paavonen,et al. Association between myocardial infarction and the mast cells in the adventitia of the infarct-related coronary artery. , 1999, Circulation.
[47] T. Hirai,et al. Consumption of vitamin E in coronary circulation in patients with variant angina. , 1999, Cardiovascular research.
[48] K. Kugiyama,et al. Vitamin E administration improves impairment of endothelium-dependent vasodilation in patients with coronary spastic angina. , 1998, Journal of the American College of Cardiology.
[49] K. Kanazawa,et al. Polymorphism of the NADH/NADPH oxidase p22 phox gene in patients with coronary artery disease. , 1998, Circulation.
[50] A. Takeshita,et al. Platelet activating factor causes hyperconstriction at the inflammatory coronary lesions in pigs in vivo , 1997, Coronary artery disease.
[51] Y. Yazaki,et al. Inflammatory cytokines cause coronary arteriosclerosis-like changes and alterations in the smooth-muscle phenotypes in pigs. , 1997, Journal of cardiovascular pharmacology.
[52] F. Crea,et al. Autonomic changes associated with spontaneous coronary spasm in patients with variant angina. , 1996, Journal of the American College of Cardiology.
[53] A. Takeshita,et al. Coronary Artery Spasm Does Not Depend on the Intracellular Calcium Store but Is Substantially Mediated by the Protein Kinase C–Mediated Pathway in a Swine Model With Interleukin-1β In Vivo , 1996 .
[54] H. Inoue,et al. Vitamin E deficiency in variant angina. , 1996, Circulation.
[55] M. Hori,et al. Elevation of the plasma histamine concentration in the coronary circulation in patients with variant angina. , 1996, The American journal of cardiology.
[56] A. Takeshita,et al. Chronic treatment with interleukin-1 beta induces coronary intimal lesions and vasospastic responses in pigs in vivo. The role of platelet-derived growth factor. , 1996, The Journal of clinical investigation.
[57] A. Takeshita,et al. Coronary artery spasm does not depend on the intracellular calcium store but is substantially mediated by the protein kinase C-mediated pathway in a swine model with interleukin-1 beta in vivo. , 1996, Circulation.
[58] H. Ishizaka,et al. Diffuse disorder of coronary artery vasomotility in patients with coronary spastic angina. Hyperreactivity to the constrictor effects of acetylcholine and the dilator effects of nitroglycerin. , 1996, Journal of the American College of Cardiology.
[59] A. Hata,et al. Angiotensin converting enzyme as a genetic risk factor for coronary artery spasm. Implication in the pathogenesis of myocardial infarction. , 1995, The Journal of clinical investigation.
[60] J. Morrow,et al. Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. , 1995, The New England journal of medicine.
[61] F. Takatsu,et al. Cigarette Smoking Is a Major Risk Factor for Coronary Spasm , 1993, Circulation.
[62] A. Castellanos,et al. Life-threatening ventricular arrhythmias in patients with silent myocardial ischemia due to coronary-artery spasm. , 1992, The New England journal of medicine.
[63] A. Takeshita,et al. Preserved endothelium-dependent vasodilation at the vasospastic site in patients with variant angina. , 1992, The Journal of clinical investigation.
[64] F. Crea,et al. Clinical and Angiographic Characteristics of 10 Patients with Prinzmetal ' s Variant Angina Pectoris Cholesterol Coronary arteriography Age CAD ( mg / dl ) ST at initial evaluation Follow-up Patient ( years ) Sex risk factors Entry Outset , 2005 .
[65] F. Crea,et al. Comparison of epicardial coronary artery tone and reactivity in Prinzmetal's variant angina and chronic stable angina pectoris. , 1991, Journal of the American College of Cardiology.
[66] A. Maseri,et al. Effect of intracoronary serotonin on coronary vessels in patients with stable angina and patients with variant angina. , 1991, The New England journal of medicine.
[67] M. Yanagisawa,et al. Increased plasma level of endothelin-1 and coronary spasm induction in patients with vasospastic angina pectoris. , 1991, Circulation.
[68] D. Mazur,et al. The hyperventilation challenge test. Another means of identifying coronary vasospasm in patients with angina-like chest pain. , 1991, Chest.
[69] K. Kugiyama,et al. Magnesium deficiency detected by intravenous loading test in variant angina pectoris. , 1990, The American journal of cardiology.
[70] F. Crea,et al. Spontaneous coronary artery spasm in variant angina is caused by a local hyperreactivity to a generalized constrictor stimulus. , 1989, Journal of the American College of Cardiology.
[71] A. Maseri,et al. Intracoronary endothelin induces myocardial ischemia by small vessel constriction in the dog. , 1989, The American journal of cardiology.
[72] A. Takeshita,et al. Increased fibrinopeptide A during anginal attacks in patients with variant angina. , 1989, Journal of the American College of Cardiology.
[73] H. Shimokawa,et al. Endothelium‐Derived Relaxing Factor and Coronary Vasospasm , 1989, Circulation.
[74] M. Nakamura,et al. Clinical characteristics and long-term prognosis of patients with variant angina. A comparative study between western and Japanese populations. , 1988, International journal of cardiology.
[75] M. Nakamura,et al. Attenuation of Endothelium‐Related Relaxation and Enhanced Responsiveness of Vascular Smooth Muscle to Histamine in Spastic Coronary Arterial Segments From Miniature Pigs , 1987, Circulation research.
[76] K. Kugiyama,et al. Induction of coronary artery spasm by acetylcholine in patients with variant angina: possible role of the parasympathetic nervous system in the pathogenesis of coronary artery spasm. , 1986, Circulation.
[77] F. Crea,et al. Provocation of coronary spasm by dopamine in patients with active variant angina pectoris. , 1986, Circulation.
[78] R. Virmani,et al. Increased adventitial mast cells in a patient with coronary spasm. , 1985, The New England journal of medicine.
[79] K. Tanaka,et al. Coronary artery spasm induced in miniature swine: angiographic evidence and relation to coronary atherosclerosis. , 1985, American heart journal.
[80] D. Waters,et al. Circadian variation in variant angina. , 1984, The American journal of cardiology.
[81] R. de Caterina,et al. A double-blind, placebo-controlled study of ketanserin in patients with Prinzmetal's angina. Evidence against a role for serotonin in the genesis of coronary vasospasm. , 1984, Circulation.
[82] F. Crea,et al. alpha-Adrenergic receptors and coronary spasm: an elusive link. , 1984, Circulation.
[83] D. Robertson,et al. Arterial and coronary sinus catecholamines in the course of spontaneous coronary artery spasm. , 1983, American heart journal.
[84] M. Winniford,et al. Alpha–adrenergic Blockade for Variant Angina: A Long–term, Double–blind, Randomized Trial , 1983, Circulation.
[85] A. Mussini,et al. Failure of Thromboxane A2 Blockade to Prevent Attacks of Vasospastic Angina , 1982, Circulation.
[86] B. McManus,et al. Sudden death in Prinzmetal's angina with coronary spasm documented by angiography. Analysis of three necropsy patients. , 1982, The American journal of cardiology.
[87] M. Bertrand,et al. Frequency of provoked coronary arterial spasm in 1089 consecutive patients undergoing coronary arteriography. , 1982, Circulation.
[88] A. Maseri,et al. ROLE OF CORONARY ARTERIAL SPASM IN SUDDEN CORONARY ISCHEMIC DEATH , 1982, Annals of the New York Academy of Sciences.
[89] F. Crea,et al. Effects of Intravenous Prostacyclin in Variant Angina , 1982, Circulation.
[90] W. Vaughn,et al. Exacerbation of Vasotonic Angina Pectoris by Propranolol , 1982, Circulation.
[91] M. Inoue,et al. Elevation of Thromboxane B2 Levels in Patients with Classic and Variant Angina Pectoris , 1981, Circulation.
[92] D. Harrison,et al. Histamine provocation of clinical coronary artery spasm: implications concerning pathogenesis of variant angina pectoris. , 1981, American heart journal.
[93] G. FitzGerald,et al. Thromboxane A2 in Vasotonic Angina Pectoris , 1981 .
[94] G. FitzGerald,et al. Thromboxane A2 in vasotonic angina pectoris: evidence from direct measurements and inhibitor trials. , 1981, The New England journal of medicine.
[95] R. Furchgott,et al. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine , 1980, Nature.
[96] R. Miller,et al. Provocation of Coronary Artery Spasm by the Cold Pressor Test: Hemodynamic, Arteriographic and Quantitative Angiographic Observations , 1980, Circulation.
[97] A. Maseri,et al. Long-term prognosis of "variant" angina with medical treatment. , 1980, The American journal of cardiology.
[98] R. Macalpin,et al. Contribution of Dynamic Vascular Wall Thickening to Luminal Narrowing During Coronary Arterial Constriction , 1980, Circulation.
[99] G. Specchia,et al. Coronary Arterial Spasm as a Cause of Exercise‐Induced ST‐Segment Elevation in Patients with Variant Angina , 1979, Circulation.
[100] W. C. Sheldon,et al. Ergonovine maleate provocative test for coronary arterial spasm. , 1978, The American journal of cardiology.
[101] G. Thiene,et al. Prinzmetal's variant angina: clinical, angiographic and pathologic correlations in two typical cases. , 1976, European journal of cardiology.
[102] J. S. Siegel. The Variant Form of Angina Pectoris , 1976, Southern medical journal.
[103] S. Syme,et al. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: prevalence of coronary and hypertensive heart disease and associated risk factors. , 1975, American journal of epidemiology.
[104] C. Marchesi,et al. Coronary Artery Spasm as a Cause of Acute Myocardial Ischemia in Man , 1975 .
[105] L. Zir,et al. Variant angina associated with angiographically demonstrated coronary artery spasm and REM sleep. , 1973, The American journal of the medical sciences.
[106] D. E. Potts,et al. Coronary arterial spasm in Prinzmetal angina. Documentation by coronary arteriography. , 1973, The New England journal of medicine.
[107] T. Cheng,et al. Variant Angina of Prinzmetal with Normal Coronary Arteriograms: A Variant of the Variant , 1973, Circulation.
[108] G. Hammond,et al. Alcohol-induced Prinzmetal variant angina. , 1973, The American journal of cardiology.
[109] G. Gensini,et al. Arteriographic Demonstration of Coronary Artery Spasm and Its Release After the Use of a Vasodilator in a Case of Angina Pectoris and in the Experimental Animal , 1962, Angiology.
[110] M. Prinzmetal,et al. Angina pectoris. I. A variant form of angina pectoris; preliminary report. , 1959, The American journal of medicine.